<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Inna Averbukh</submitter><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-BIAD2708</full_dataset_link><repository>bioimages</repository><figure_sub>Specimen</figure_sub><figure_sub>Funding</figure_sub><figure_sub>Study Component</figure_sub><figure_sub>Biosample</figure_sub><figure_sub>organisation</figure_sub><figure_sub>Associations</figure_sub><figure_sub>Annotation</figure_sub><figure_sub>Image acquisition</figure_sub><pubmed_authors>Sean Bendall</pubmed_authors><pubmed_authors>Michael Angelo</pubmed_authors><pubmed_authors>Inna Averbukh</pubmed_authors><pubmed_authors>Hadeesha Piyadasa</pubmed_authors></additional><is_claimable>false</is_claimable><name>Topological encoding of risk in ductal carcinoma in situ</name><description>Over 50,000 women in the US are diagnosed each year with ductal carcinoma in situ (DCIS), a preinvasive breast lesion of which only a subset will progress to invasive cancer. Because non-progressors cannot be identified at diagnosis, most patients undergo aggressive treatment with significant side effects. Here, we developed a high-dimensional spatial proteomic panel to comprehensively characterize epithelial and myoepithelial cell states and their surrounding microenvironment in a clinically annotated DCIS cohort (n = 162). Combined with deep learning–based segmentation, we profiled over one million single cells and mapped spatial niche organization across epithelial, stromal, and immune compartments. A composite spatial confidence score integrating epithelial organization, stromal desmoplasia, collagen branching and alignment, cell composition, and cell phenotypes, and compartmentalized ductal marker expression identified a high-confidence non-progressor group (46% of cases) with a negative predictive value of 100%. These data revealed conserved protective architectures and coordinated immune–stromal-tumor niches that maintain ductal integrity, establishing a framework for DCIS risk stratification and treatment de-escalation.</description><dates><release>2026-01-19T00:00:00Z</release><modification>2026-04-29T15:31:43.206Z</modification><creation>2026-01-19T19:49:56.123Z</creation></dates><accession>S-BIAD2708</accession><cross_references/></HashMap>